Supplement
Rosemary leaf extract clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
3 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Universidad Autonoma de Zacatecas (1) · awatef Sassi (1) · Laval University (1)
Often tested with
Tested in the same studies.
Cinnamon (1) · Origanum vulgare (1) · Ginger extract (1) · Black pepper (1)
Studies
Open first, then newest update. How each study uses rosemary leaf extract is read from its arms, and is right about nine times in ten.
Testing it · 3
- Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes (T2DM)Active, not recruitingNot applicableUniversidad Autonoma de ZacatecasNCT07541729Written as Rosmarinus officinalis extract
- Rosemary Infusion for Hypertension With HypertriglyceridemiaCompletedNot applicableawatef SassiNCT07352124Written as Rosemary infusion
- Impact of Spices and Herbs on Endothelial FunctionCompletedNot applicableLaval UniversityNCT01085019Written as Rosemary
Codes
What other systems call rosemary leaf extract · ClinicalTrials.gg INT001554
- MeSH (NLM) C000713808rosemary leaf extractOne source NLM
- UNII (FDA) IJ67X351P9ROSEMARYOne source NLM
- RxNorm 317702One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000713808 | rosemary leaf extract | One source NLM |
| UNII (FDA) | IJ67X351P9 | ROSEMARY | One source NLM |
| RxNorm | 317702 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.